基托桑-石墨烯量子点基活性膜作为智能伤口包裹
Elisabete Regina Fernandes Ramos Ribeiro1, Luana Barbosa Correa1, Eduardo Ricci-Junior2
1Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Nanoradiopharmaceuticals and Synthesis of Novel Radiopharmaceuticals, Rio de Janeiro, 21941906, Brazil.
Journal of drug delivery science and technology
|April 23, 2024
概括
这项研究开发了素-石墨烯量子点膜,用于感染的伤口愈合. 这些生物相容的薄膜显示出增强的抗菌活性,并促进伤口愈合,提供了一个有前途的新疗法.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 伤口愈合是复杂的,特别是在感染或慢性疾病中.
- 石墨烯量子点 (GQD) 提供生物相容性,机械强度和稳定性.
- 奇托具有有益的抗菌,抗炎和生物相容性质.
研究的目的:
- 开发和评估素-石墨烯量子点膜,用于感染伤口的应用.
- 评估这些复合膜的结构,机械和生物特性.
主要方法:
- 素-石墨烯薄膜是通过酸性溶液加工制造的,随后是溶剂蒸发和干燥.
- 描述涉及扫描电子显微镜,X射线衍射,原子力显微镜,拉曼光谱和热重力测量分析.
- 生物评估包括伤口愈合测试,溶血潜力和酸盐,细胞因子和胀潜力的评估.
主要成果:
- 基托桑-石墨烯薄膜表现出灵活性和组织良好的结构.
- 这些膜表现出增强的抗菌活性,并促进细胞迁移.
- 这些材料有效地保持了伤口的湿度,同时显示出低血解活性.
结论:
- 素-石墨烯量子点膜是一种有前途且有效的材料,用于对抗受感染的伤口.
- 开发的薄膜具有用于先进的伤口护理应用的有利特性.
- 这项研究强调了纳米复合材料在再生医学中的潜力.
相关概念视频
Drug Absorption Mechanism: Passive Membrane Transport
Passive transport is a method of drug absorption where small, lipid-soluble drugs can move across the cell membrane. This movement happens along the concentration gradient, which is a natural flow from higher to lower concentration areas. The speed at which the drug moves is directly related to its lipid–water partition coefficient. This means that the more a drug dissolves in lipids, the faster it diffuses or spreads throughout the body. It is important to note that most drugs are either weak...
Local Anesthetics: Chemistry and Structure-Activity Relationship
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
Local Anesthetics: Mechanism of Action
Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia
Depending on the target organ, local anesthetics (LAs) can be administered via various routes. In surface anesthesia, LAs are applied directly to the surface of the skin or mucous membranes. It is widely used for topical skin numbing before venipuncture or minor surgical procedures. Commonly used surface local anesthetics are lidocaine or benzocaine sprays or creams. Surface anesthesia occurs within 5 minutes and lasts for about 60 minutes. One of the main disadvantages of topical anesthesia is...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


